General
CSL injects $2.3b into US for valuable blood plasma
Australia’s largest biotech company plans to expand its US presence with a $US1.5 billion ($A2.3 billion) investment that will allow it to manufacture more therapies derived from blood…
Continue Reading
-
Noosa News22 hours agoMan charged after ‘beautiful and gentle’ Olivia, 17, killed in alleged Margate hit-and-run a month before birthday
-
General4 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
Business7 hours agoSolid superannuation gains continue to roll in
-
Noosa News24 hours agoBusiness owner reveals torment of tax office’s seven-year pursuit